Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR.
Sun Y, Gao Y, Dong M, Li J, Li X, He N, Song H, Zhang M, Ji K, Wang J, Gu Y, Wang Y, Du L, Liu Y, Wang Q, Zhai H, Sun D, Liu Q, Xu C.
Sun Y, et al. Among authors: li j, li x.
J Exp Clin Cancer Res. 2023 Jun 3;42(1):140. doi: 10.1186/s13046-023-02692-3.
J Exp Clin Cancer Res. 2023.
PMID: 37270563
Free PMC article.